title: Attitudes in 2013 to Monitoring Intracranial Pressure for Traumatic Intracerebral Haemorrhage.
abstract: Recent research has been equivocal regarding the usefulness of intracranial pressure (ICP) monitoring for traumatic intracerebral haemorrhage (ICH). We aimed to investigate attitudes of clinicians from as wide an international audience as possible.
  
  
  
  A SurveyMonkey® questionnaire was distributed to individuals, including members of the Society of British Neurological Surgeons, the European Brain Injury Consortium, the Euroacademia Multidisciplinaria Neurotraumatologica and the neurotrauma committee of the World Federation of Neurosurgical Societies.
  
  
  
  Ninety-eight participants from at least 25 different countries completed the survey (86 surgeons). ICP was routinely monitored by 76 % and would be monitored by 5 % more if they had equipment. ICP monitoring was valued (0 = not at all important, 10 = critically important) as 10 by 21 % (median = 8; Q1 = 7, Q3 = 9). Responders were aware of 16 trials that investigated the value of ICP monitoring in neurotrauma, including BEST TRIP (n = 35), Rescue ICP (n = 13) and DECRA (n = 8). Other results are discussed.
  
  
  
  Despite equivocation in the literature, we found that ICP monitoring continues to be routinely performed and is highly valued. Interestingly, only 36 % of responders were aware of the BEST TRIP trial, which found no difference in outcome between patients with a head injury managed with or without ICP monitoring.
authors.affiliation: Neurosurgical Trials Unit, Newcastle University, 3-4 Claremont Terrace, Newcastle upon Tyne, NE2 4AE, UK. Richard.francis2@ncl.ac.uk.
authors.forename: Richard
authors.initials: R
authors.lastname: Francis
authors.affiliation: Newcastle University, Newcastle upon Tyne, UK.
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Gregson
authors.affiliation: Newcastle University, Newcastle upon Tyne, UK.
authors.forename: A David
authors.initials: AD
authors.lastname: Mendelow
mesh_terms: D000072077:Anesthetists; D001291:Attitude of Health Personnel; D001463:Barbiturates / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D020202:Cerebral Hemorrhage, Traumatic / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D002560:Cerebrovascular Circulation; D003422:Critical Care; D056424:Decompressive Craniectomy; D019468:Disease Management; D006801:Humans; D007036:Hypothermia, Induced / Q000379:methods; D019586:Intracranial Hypertension / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D007427:Intracranial Pressure; D008991:Monitoring, Physiologic / Q000379:methods*; D000069471:Neurosurgeons; D009726:Nurses; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000627:therapeutic use; D011795:Surveys and Questionnaires
chemical_list: D001463:Barbiturates; D002316:Cardiotonic Agents; D049994:Sodium Potassium Chloride Symporter Inhibitors
keywords: Cerebral perfusion pressure; Intracerebral haemorrhage; Intracranial pressure; Trauma